Tech Company Financing Transactions
Surge Funding Round
Surge, based in San Francisco, raised $8.1 million from Eurazeo, 50 Partners and Boutique Venture Partners.
Transaction Overview
Company Name
Announced On
3/28/2024
Transaction Type
Venture Equity
Amount
$8,100,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to enable the opening of SurgeLab�, a premier laboratory dedicated to the discovery of immune biomarkers, and the finalization of PreCyte®'s industrialization.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
70 Douglass St
San Francisco, CA 94114
USA
San Francisco, CA 94114
USA
Phone
Website
Email Address
Overview
Surge is a startup founded in mid-2021. Our multidisciplinary team comprises engineers and physicians from Stanford University, Sorbonne University, and École Polytechnique. Surge personalizes the care of patients undergoing surgery by providing an accurate prediction of postoperative infections based on a single-cell immune system profile.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julien Hédou
Chief Operating Officer
Valentin Picot
Co-Founder
Brice Gaudilliere
VP - Product Management
Benjamin Choisy
Browse more venture capital transactions:
Prev: 3/28/2024: Sprocket Security venture capital transaction
Next: 3/28/2024: SydeLabs venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs